Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free DOX Stock Alerts

Amdocs (DOX) Financials

Amdocs logo
$61.93 +2.00 (+3.34%)
Closing price 04:00 PM Eastern
Extended Trading
$61.59 -0.34 (-0.55%)
As of 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Amdocs

Annual Income Statements for Amdocs

This table shows Amdocs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 446 409 437 354 479 498 688 550 541 493 565
Consolidated Net Income / (Loss)		 446 409 437 354 479 498 688 550 543 496 568
Net Income / (Loss) Continuing Operations		 446 409 437 354 479 498 688 550 543 496 568
Total Pre-Tax Income 		513 485 513 422 568 583 814 648 636 591 693
Total Operating Income		 516 483 517 428 570 595 599 665 654 629 732
Total Gross Profit		 1,294 1,310 1,359 1,380 1,433 1,413 1,478 1,619 1,728 1,755 1,722
Total Revenue		 3,644 3,718 3,867 3,975 4,087 4,169 4,289 4,577 4,888 5,005 4,533
Operating Revenue		 3,644 3,718 3,867 3,975 4,087 4,169 4,289 4,577 4,888 5,005 4,533
Total Cost of Revenue		 2,349 2,408 2,508 2,595 2,653 2,756 2,811 2,958 3,160 3,250 2,811
Operating Cost of Revenue		 2,349 2,408 2,508 2,595 2,653 2,756 2,811 2,958 3,160 3,250 2,811
Total Operating Expenses		 778 827 842 951 864 819 879 954 1,074 1,127 990
Selling, General & Admin Expense		 440 465 473 481 492 459 487 529 571 573 506
Research & Development Expense		 255 252 259 277 274 282 313 355 375 361 341
Amortization Expense		 70 110 110 108 97 78 79 71 57 62 62
Restructuring Charge		 13 - - - - - 0.00 0.00 71 131 81
Total Other Income / (Expense), net		 -2.54 1.56 -4.42 -6.77 -1.86 -11 216 -16 -18 -38 -38
Other Income / (Expense), net		 - - -4.42 - -1.86 -11 216 -16 -18 -38 -38
Income Tax Expense		 67 75 76 67 88 85 126 99 93 95 125
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - 0.00 0.00 2.25 3.12 3.07
Basic Earnings per Share		 $2.89 $2.74 $2.99 $2.49 $3.49 $3.73 $5.36 $4.47 $4.52 $4.27 $5.08
Weighted Average Basic Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Diluted Earnings per Share		 $2.85 $2.71 $2.96 $2.47 $3.47 $3.71 $5.32 $4.44 $4.49 $4.25 $5.05
Weighted Average Diluted Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Weighted Average Basic & Diluted Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 134.77M 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Cash Dividends to Common per Share		 $0.67 $0.76 $0.86 $0.97 $1.11 $1.27 $1.41 $1.55 $1.70 $1.87 $2.06

Quarterly Income Statements for Amdocs

No quarterly income statements for Amdocs are available.

Annual Cash Flow Statements for Amdocs

This table details how cash moves in and out of Amdocs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents		 -68 -267 -119 -231 53 512 -274 -136 -53 -174 -21
Net Cash From Operating Activities		 773 620 636 557 656 658 926 757 823 724 749
Net Cash From Continuing Operating Activities		 773 620 636 557 656 658 926 757 823 724 749
Net Income / (Loss) Continuing Operations		 446 409 437 354 479 498 688 550 543 496 568
Consolidated Net Income / (Loss)		 446 409 437 354 479 498 688 550 543 496 568
Depreciation Expense		 175 212 215 211 206 198 209 225 198 195 195
Amortization Expense		 - - - 0.00 0.00 0.14 0.55 0.56 0.58 0.60 0.61
Non-Cash Adjustments To Reconcile Net Income		 39 36 40 49 39 35 -170 65 88 110 108
Changes in Operating Assets and Liabilities, net		 113 -37 -55 -57 -68 -73 198 -82 -7.18 -78 -123
Net Cash From Investing Activities		 -380 -441 -185 -362 -87 -462 -329 -263 -224 -127 -2.06
Net Cash From Continuing Investing Activities		 -380 -441 -185 -362 -87 -462 -329 -263 -224 -127 -2.06
Purchase of Property, Plant & Equipment		 -121 -130 -133 -231 -128 -206 -210 -227 -124 -105 -104
Acquisitions		 -263 -283 -18 -355 -61 -249 -143 -24 -122 -87 -86
Purchase of Investments		 -250 -371 -282 -76 0.00 -0.75 -277 -34 0.00 -9.06 0.00
Sale and/or Maturity of Investments		 253 362 278 303 101 0.00 18 22 26 69 170
Other Investing Activities, net		 1.41 -19 -30 -3.16 0.62 -6.10 -6.08 -8.53 -4.30 5.32 18
Net Cash From Financing Activities		 -461 -446 -570 -426 -517 315 -871 -630 -651 -771 -768
Net Cash From Continuing Financing Activities		 -461 -446 -570 -426 -517 315 -871 -630 -651 -771 -768
Repurchase of Common Equity		 -454 -413 -341 -419 -398 -361 -680 -508 -490 -563 -551
Payment of Dividends		 -101 -109 -122 -87 -152 -164 -177 -186 -199 -216 -228
Other Financing Activities, net		 84 96 92 81 34 96 87 65 38 8.17 12
Cash Interest Paid		 0.55 0.58 1.15 2.01 7.35 5.39 19 17 19 35 41
Cash Income Taxes Paid		 51 50 68 56 76 45 146 80 156 188 122

Quarterly Cash Flow Statements for Amdocs

No quarterly cash flow statements for Amdocs are available.

Annual Balance Sheets for Amdocs

This table presents Amdocs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets		 5,325 5,331 5,279 5,348 5,293 6,342 6,512 6,390 6,426 6,386 6,250
Total Current Assets		 2,378 2,100 2,048 1,721 1,676 2,075 2,067 2,003 1,912 1,771 1,592
Cash & Equivalents		 1,036 769 650 419 472 983 709 573 520 346 325
Short-Term Investments		 318 327 330 100 0.00 0.75 257 245 222 168 0.00
Accounts Receivable		 715 819 865 972 988 861 867 947 944 1,028 936
Prepaid Expenses		 159 186 204 230 216 230 235 238 225 228 331
Plant, Property, & Equipment, net		 309 332 356 497 525 608 699 794 791 756 769
Total Noncurrent Assets		 2,637 2,899 2,875 3,131 3,092 3,659 3,746 3,593 3,723 3,859 3,889
Goodwill		 2,049 2,212 2,221 2,445 2,463 2,579 2,623 2,663 2,749 2,845 2,891
Intangible Assets		 253 282 177 265 205 296 259 178 182 161 156
Other Noncurrent Operating Assets		 336 406 477 420 424 784 864 752 793 854 842
Total Liabilities & Shareholders' Equity		 5,325 5,331 5,279 5,348 5,293 6,342 6,512 6,390 6,426 6,386 6,250
Total Liabilities		 1,918 1,878 1,705 1,856 1,750 2,676 2,877 2,830 2,859 2,887 2,779
Total Current Liabilities		 1,364 1,366 1,173 1,295 1,208 1,216 1,304 1,253 1,353 1,471 1,359
Accounts Payable		 112 137 126 195 177 110 121 134 293 306 371
Accrued Expenses		 609 612 668 707 648 594 612 613 635 779 623
Current Deferred Revenue		 198 173 113 132 118 127 237 254 171 115 119
Current Employee Benefit Liabilities		 224 244 265 261 266 227 274 209 215 231 207
Other Current Liabilities		 - - - - 0.00 59 59 43 40 40 39
Total Noncurrent Liabilities		 554 512 532 561 542 1,460 1,573 1,577 1,505 1,416 1,420
Long-Term Debt		 - - - - 0.00 644 645 645 646 646 647
Noncurrent Deferred & Payable Income Tax Liabilities		 306 227 219 225 208 258 305 312 253 198 219
Other Noncurrent Operating Liabilities		 248 285 313 336 335 558 624 620 607 572 555
Total Equity & Noncontrolling Interests		 3,407 3,454 3,574 3,492 3,542 3,665 3,635 3,560 3,567 3,499 3,471
Total Preferred & Common Equity		 3,407 3,454 3,574 3,449 3,500 3,623 3,593 3,518 3,524 3,457 3,429
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3,407 3,454 3,574 3,449 3,500 3,623 3,593 3,518 3,524 3,457 3,429
Common Stock		 3,187 3,327 3,463 3,592 3,672 3,812 3,956 4,110 4,249 4,418 4,578
Retained Earnings		 3,848 4,145 4,457 4,674 5,013 5,342 5,851 6,212 6,550 6,828 7,165
Treasury Stock		 -3,611 -4,025 -4,365 -4,784 -5,182 -5,543 -6,223 -6,732 -7,221 -7,784 -8,336
Accumulated Other Comprehensive Income / (Loss)		 -17 6.10 19 -33 -2.55 12 9.34 -72 -53 -4.41 23
Noncontrolling Interest		 - - 0.00 43 43 43 43 43 43 42 41

Quarterly Balance Sheets for Amdocs

No quarterly balance sheets for Amdocs are available.

Annual Metrics And Ratios for Amdocs

This table displays calculated financial ratios and metrics derived from Amdocs' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 2.24% 2.05% 4.01% 2.78% 2.81% 2.02% 2.87% 6.72% 6.79% 2.40% -9.43%
EBITDA Growth		 4.91% 0.61% 4.73% -12.13% 20.97% 1.06% 30.93% -14.67% -4.68% -5.75% 13.01%
EBIT Growth		 4.10% -6.36% 6.16% -16.50% 32.59% 2.72% 39.60% -20.37% -1.86% -7.12% 17.29%
NOPAT Growth		 4.91% -9.00% 7.98% -18.27% 33.58% 5.53% -0.29% 11.32% -0.96% -5.41% 13.53%
Net Income Growth		 5.70% -8.26% 6.72% -18.87% 35.29% 3.84% 38.27% -20.17% -1.19% -8.59% 14.40%
EPS Growth		 8.78% -4.91% 9.23% -16.55% 40.49% 6.92% 43.40% -16.54% 1.13% -5.35% 18.82%
Operating Cash Flow Growth		 8.93% -19.72% 2.56% -12.40% 17.79% 0.27% 40.67% -18.26% 8.71% -11.94% 3.41%
Free Cash Flow Firm Growth		 -9.51% -65.54% 228.41% -104.53% 2,195.26% -60.00% 302.88% -20.59% -3.02% -22.83% 19.36%
Invested Capital Growth		 4.19% 12.54% 1.43% 14.58% 3.30% 11.54% -3.24% 2.21% 2.44% 4.64% 4.45%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 35.52% 35.24% 35.16% 34.71% 35.08% 33.90% 34.46% 35.38% 35.35% 35.07% 37.98%
EBITDA Margin		 18.96% 18.69% 18.82% 16.09% 18.93% 18.75% 23.87% 19.09% 17.04% 15.68% 19.62%
Operating Margin		 14.16% 12.99% 13.38% 10.78% 13.94% 14.27% 13.96% 14.53% 13.38% 12.56% 16.14%
EBIT Margin		 14.16% 12.99% 13.26% 10.78% 13.90% 13.99% 18.99% 14.17% 13.02% 11.81% 15.29%
Profit (Net Income) Margin		 12.25% 11.01% 11.30% 8.92% 11.73% 11.94% 16.05% 12.01% 11.11% 9.92% 12.53%
Tax Burden Percent		 86.90% 84.45% 85.17% 84.07% 84.43% 85.35% 84.54% 84.75% 85.32% 83.97% 81.90%
Interest Burden Percent		 99.51% 100.32% 100.00% 98.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 13.10% 15.55% 14.83% 15.93% 15.57% 14.65% 15.46% 15.25% 14.68% 16.03% 18.10%
Return on Invested Capital (ROIC)		 20.13% 16.89% 17.10% 12.94% 15.92% 15.63% 15.02% 16.81% 16.27% 14.87% 16.14%
ROIC Less NNEP Spread (ROIC-NNEP)		 20.32% 16.76% 17.50% 13.69% 16.23% 18.37% -49.97% 22.44% 27.43% -164.59% 2.28%
Return on Net Nonoperating Assets (RNNOA)		 -7.02% -4.96% -4.67% -2.90% -2.29% -1.81% 3.84% -1.54% -1.04% -0.82% 0.15%
Return on Equity (ROE)		 13.12% 11.93% 12.43% 10.03% 13.63% 13.81% 18.86% 15.27% 15.24% 14.05% 16.29%
Cash Return on Invested Capital (CROIC)		 16.03% 5.09% 15.68% -0.66% 12.67% 4.72% 18.32% 14.63% 13.86% 10.33% 11.79%
Operating Return on Assets (OROA)		 9.82% 9.07% 9.67% 8.06% 10.67% 10.03% 12.67% 10.05% 9.93% 9.23% 10.97%
Return on Assets (ROA)		 8.49% 7.68% 8.23% 6.67% 9.01% 8.56% 10.71% 8.52% 8.47% 7.75% 8.99%
Return on Common Equity (ROCE)		 13.12% 11.93% 12.43% 9.97% 13.47% 13.65% 18.64% 15.09% 15.05% 13.88% 16.10%
Return on Equity Simple (ROE_SIMPLE)		 13.10% 11.85% 12.22% 10.28% 13.70% 13.74% 19.16% 15.62% 15.41% 14.36% 0.00%
Net Operating Profit after Tax (NOPAT)		 448 408 441 360 481 508 506 563 558 528 599
NOPAT Margin		 12.31% 10.97% 11.39% 9.06% 11.77% 12.18% 11.80% 12.31% 11.42% 10.55% 13.22%
Net Nonoperating Expense Percent (NNEP)		 -0.19% 0.13% -0.40% -0.76% -0.32% -2.74% 64.99% -5.62% -11.15% 179.45% 13.87%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 13.40% 13.25% 12.73% 14.55%
Cost of Revenue to Revenue		 64.48% 64.76% 64.85% 65.29% 64.92% 66.10% 65.54% 64.62% 64.65% 64.93% 62.02%
SG&A Expenses to Revenue		 12.08% 12.50% 12.23% 12.10% 12.05% 11.00% 11.36% 11.55% 11.68% 11.45% 11.17%
R&D to Revenue		 7.00% 6.79% 6.70% 6.96% 6.70% 6.77% 7.30% 7.75% 7.67% 7.21% 7.52%
Operating Expenses to Revenue		 21.36% 22.24% 21.78% 23.93% 21.14% 19.64% 20.50% 20.85% 21.97% 22.51% 21.84%
Earnings before Interest and Taxes (EBIT)		 516 483 513 428 568 583 814 648 636 591 693
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 691 695 728 640 774 782 1,024 874 833 785 889
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.27 2.22 2.36 2.50 2.44 2.01 2.66 2.71 2.83 2.97 2.70
Price to Tangible Book Value (P/TBV)		 6.99 8.00 7.17 11.66 10.26 9.73 13.42 14.08 16.84 22.74 24.22
Price to Revenue (P/Rev)		 2.12 2.07 2.18 2.17 2.09 1.75 2.22 2.08 2.04 2.05 2.04
Price to Earnings (P/E)		 17.32 18.77 19.30 24.30 17.80 14.62 13.86 17.34 18.47 20.81 16.40
Dividend Yield		 1.35% 1.49% 1.49% 1.63% 1.82% 2.35% 1.94% 2.03% 2.06% 2.14% 2.51%
Earnings Yield		 5.77% 5.33% 5.18% 4.12% 5.62% 6.84% 7.21% 5.77% 5.41% 4.80% 6.10%
Enterprise Value to Invested Capital (EV/IC)		 2.90 2.65 2.87 2.74 2.64 2.07 2.80 2.77 2.86 2.88 2.54
Enterprise Value to Revenue (EV/Rev)		 1.81 1.83 1.93 2.05 1.98 1.70 2.16 2.05 2.03 2.09 2.12
Enterprise Value to EBITDA (EV/EBITDA)		 9.55 9.77 10.24 12.72 10.47 9.06 9.05 10.76 11.93 13.30 10.82
Enterprise Value to EBIT (EV/EBIT)		 12.78 14.05 14.52 18.99 14.27 12.14 11.38 14.49 15.61 17.66 13.89
Enterprise Value to NOPAT (EV/NOPAT)		 14.71 16.63 16.91 22.59 16.85 13.95 18.30 16.68 17.80 19.78 16.06
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.53 10.94 11.71 14.60 12.35 10.76 10.01 12.42 12.08 14.41 12.85
Enterprise Value to Free Cash Flow (EV/FCFF)		 18.47 55.17 18.44 0.00 21.16 46.22 15.01 19.17 20.90 28.46 21.99
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.06 0.06 0.00 0.00 0.00 0.20 0.18 0.18 0.18 0.18 0.19
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.18 0.18 0.18 0.18 0.18 0.19
Financial Leverage		 -0.35 -0.30 -0.27 -0.21 -0.14 -0.10 -0.08 -0.07 -0.04 0.01 0.07
Leverage Ratio		 1.55 1.55 1.51 1.50 1.51 1.61 1.76 1.79 1.80 1.81 1.81
Compound Leverage Factor		 1.54 1.56 1.51 1.48 1.51 1.61 1.76 1.79 1.80 1.81 1.81
Debt to Total Capital		 6.07% 5.47% 0.00% 0.00% 0.00% 16.87% 15.06% 15.34% 15.33% 15.59% 15.71%
Short-Term Debt to Total Capital		 6.07% 5.47% 0.00% 0.00% 0.00% 2.27% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 14.61% 15.06% 15.34% 15.33% 15.59% 15.71%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 1.24% 1.20% 0.96% 0.99% 1.01% 1.02% 1.02% 1.00%
Common Equity to Total Capital		 93.93% 94.53% 100.00% 98.76% 98.80% 82.16% 83.95% 83.65% 83.65% 83.39% 83.29%
Debt to EBITDA		 0.32 0.29 0.00 0.00 0.00 0.95 0.63 0.74 0.78 0.82 0.73
Net Debt to EBITDA		 -1.64 -1.29 0.00 0.00 0.00 -0.31 -0.31 -0.20 -0.12 0.17 0.36
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.82 0.63 0.74 0.78 0.82 0.73
Debt to NOPAT		 0.49 0.49 0.00 0.00 0.00 1.47 1.27 1.15 1.16 1.22 1.08
Net Debt to NOPAT		 -2.53 -2.20 0.00 0.00 0.00 -0.47 -0.63 -0.31 -0.17 0.25 0.54
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 1.27 1.27 1.15 1.16 1.22 1.08
Altman Z-Score		 4.66 4.70 5.40 5.11 5.48 3.93 4.46 4.57 4.72 4.78 4.74
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.61% 1.22% 1.18% 1.16% 1.18% 1.20% 1.21% 1.20%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.74 1.54 1.75 1.33 1.39 1.71 1.59 1.60 1.41 1.20 1.17
Quick Ratio		 1.52 1.40 1.57 1.15 1.21 1.52 1.41 1.41 1.25 1.05 0.93
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 357 123 404 -18 383 153 617 490 475 367 438
Operating Cash Flow to CapEx		 641.16% 476.79% 476.87% 241.08% 512.45% 320.25% 439.94% 333.04% 661.48% 686.69% 720.62%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.69 0.70 0.73 0.75 0.77 0.72 0.67 0.71 0.76 0.78 0.72
Accounts Receivable Turnover		 5.09 4.85 4.59 4.33 4.17 4.51 4.96 5.05 5.17 5.07 4.62
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 12.18 11.60 11.25 9.33 8.00 7.36 6.56 6.13 6.17 6.47 5.95
Accounts Payable Turnover		 18.46 19.37 19.06 16.16 14.29 19.23 24.30 23.14 14.77 10.85 8.30
Days Sales Outstanding (DSO)		 71.66 75.26 79.45 84.32 87.50 80.94 73.53 72.32 70.62 71.94 79.08
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 19.78 18.84 19.15 22.58 25.54 18.98 15.02 15.77 24.70 33.66 43.95
Cash Conversion Cycle (CCC)		 51.88 56.41 60.31 61.74 61.96 61.95 58.51 56.55 45.92 38.28 35.12
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,273 2,558 2,594 2,973 3,071 3,425 3,314 3,387 3,470 3,631 3,793
Invested Capital Turnover		 1.64 1.54 1.50 1.43 1.35 1.28 1.27 1.37 1.43 1.41 1.22
Increase / (Decrease) in Invested Capital		 91 285 37 378 98 354 -111 73 83 161 161
Enterprise Value (EV)		 6,593 6,786 7,449 8,135 8,104 7,080 9,263 9,396 9,935 10,440 9,626
Market Capitalization		 7,727 7,682 8,429 8,611 8,533 7,278 9,541 9,526 9,989 10,266 9,263
Book Value per Share		 $21.74 $22.85 $24.29 $23.89 $24.97 $26.88 $27.31 $28.17 $29.16 $29.46 $30.38
Tangible Book Value per Share		 $7.05 $6.35 $7.99 $5.12 $5.94 $5.55 $5.41 $5.42 $4.91 $3.85 $3.39
Total Capital		 3,627 3,654 3,574 3,492 3,542 4,409 4,280 4,205 4,213 4,145 4,118
Total Debt		 220 200 0.00 0.00 0.00 744 645 645 646 646 647
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 644 645 645 646 646 647
Net Debt		 -1,134 -896 -980 -519 -472 -240 -321 -173 -97 132 322
Capital Expenditures (CapEx)		 121 130 133 231 128 206 210 227 124 105 104
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -119 -161 -104 -93 -3.99 -26 -202 -68 -184 -214 -92
Debt-free Net Working Capital (DFNWC)		 1,235 934 876 426 468 958 764 750 558 300 233
Net Working Capital (NWC)		 1,015 734 876 426 468 858 764 750 558 300 233
Net Nonoperating Expense (NNE)		 2.21 -1.31 3.77 5.69 1.57 9.76 -182 14 15 32 31
Net Nonoperating Obligations (NNO)		 -1,134 -896 -980 -519 -472 -240 -321 -173 -97 132 322
Total Depreciation and Amortization (D&A)		 175 212 215 211 206 199 209 225 196 194 196
Debt-free, Cash-free Net Working Capital to Revenue		 -3.28% -4.34% -2.69% -2.35% -0.10% -0.61% -4.71% -1.48% -3.77% -4.28% -2.02%
Debt-free Net Working Capital to Revenue		 33.89% 25.13% 22.64% 10.71% 11.44% 22.99% 17.81% 16.40% 11.42% 6.00% 5.15%
Net Working Capital to Revenue		 27.85% 19.75% 22.64% 10.71% 11.44% 20.59% 17.81% 16.40% 11.42% 6.00% 5.15%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.89 $2.74 $2.99 $2.49 $0.00 $3.73 $5.36 $4.47 $4.52 $4.27 $5.08
Adjusted Weighted Average Basic Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Adjusted Diluted Earnings per Share		 $2.85 $2.71 $2.96 $2.47 $0.00 $3.71 $5.32 $4.44 $4.49 $4.25 $5.05
Adjusted Weighted Average Diluted Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 151.15M 147.13M 144.39M 140.18M 0.00 131.54M 124.87M 120.84M 117.35M 112.89M 108.45M
Normalized Net Operating Profit after Tax (NOPAT)		 460 408 441 432 481 508 506 563 618 638 665
Normalized NOPAT Margin		 12.62% 10.97% 11.39% 10.86% 11.77% 12.18% 11.80% 12.31% 12.65% 12.75% 14.67%
Pre Tax Income Margin		 14.09% 13.04% 13.26% 10.61% 13.90% 13.99% 18.99% 14.17% 13.02% 11.81% 15.29%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 22.59% 26.70% 27.82% 24.63% 31.79% 32.95% 25.78% 33.86% 37.03% 43.53% 40.23%
Augmented Payout Ratio		 124.35% 127.70% 105.79% 142.92% 114.81% 105.45% 124.56% 126.40% 127.19% 156.99% 137.34%

Quarterly Metrics And Ratios for Amdocs

No quarterly metrics and ratios for Amdocs are available.


Financials Breakdown Chart

Amdocs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amdocs' financial year ends in September. Their financial year 2025 ended on September 30, 2025.

Amdocs' net income appears to be on an upward trend, with a most recent value of $567.77 million in 2025, rising from $446.16 million in 2015. The previous period was $496.32 million in 2024. View Amdocs' forecast to see where analysts expect Amdocs to go next.

Amdocs' total operating income in 2025 was $731.66 million, based on the following breakdown:
  • Total Gross Profit: $1.72 billion
  • Total Operating Expenses: $989.92 million

Over the last 10 years, Amdocs' total revenue changed from $3.64 billion in 2015 to $4.53 billion in 2025, a change of 24.4%.

Amdocs' total liabilities were at $2.78 billion at the end of 2025, a 3.7% decrease from 2024, and a 44.9% increase since 2015.

In the past 10 years, Amdocs' cash and equivalents has ranged from $325.00 million in 2025 to $1.04 billion in 2015, and is currently $325.00 million as of their latest financial filing in 2025.

Over the last 10 years, Amdocs' book value per share changed from 21.74 in 2015 to 30.38 in 2025, a change of 39.7%.


Related Companies

Financial statements for NASDAQ:DOX last updated on 12/18/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
What Expenses Can Be Deducted From Capital Gains Tax This Year?
Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...
SmartAsset | Sponsoredtc pixel
Distracted Americans set to miss out on quadrillions
Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...
Brownstone Research | Sponsoredtc pixel